Protocol Ledger | Public ClinicalTrials.gov v2 & FDA Drugs@FDA Clinical Research Directory
Protocol Ledger reconciles 54,890 interventional Phase II and Phase III clinical trial studies (2018 to 2026) across 22,436 canonical hospital research sites (10,046 California studies) and 4,879 consolidated biopharma, academic, and federal sponsors paired with 1,184 FDA Drugs@FDA original NDA and BLA approvals.
Browse the Hospital & Sponsor Directory, inspect the 3D Clinical Site Map, compare organizations in Side-by-Side Comparison, explore all clinical trial research studies, review our reconciliation methodology, or configure privacy and browser analytics controls.